From "Azalla" to Anandamide: Distilling the Therapeutic Potential of Cannabinoids
- PMID: 29223222
- PMCID: PMC5752109
- DOI: 10.1016/j.biopsych.2017.11.017
From "Azalla" to Anandamide: Distilling the Therapeutic Potential of Cannabinoids
Conflict of interest statement
The authors report no biomedical financial interests or potential conflicts of interest.
Figures
Comment on
-
Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety.Biol Psychiatry. 2017 Oct 1;82(7):488-499. doi: 10.1016/j.biopsych.2017.03.002. Epub 2017 Mar 15. Biol Psychiatry. 2017. PMID: 28438413 Free PMC article.
References
-
- Mechoulam R, Ben-Shabat S. From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis. Nat Prod Rep. 1999;16:131–143. - PubMed
-
- Radhakrishnan RA, Addy P, Sewell RA, Skosnik PD, Ranganathan M, D’Souza DC. Cannabis, cannabinoids and the link with psychosis. In: Madras B, Kuhar M, editors. The Effects of Drug Abuse on the Human Nervous System. San Diego, CA: Academic Press; 2014. pp. 423–474.
-
- Di Marzo V. A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientists. Trends Pharmacol Sci. 2006;27:134–140. - PubMed
-
- Mechoulam R, Hanus L. A historical overview of chemical research on cannabinoids. Chem Phys Lipids. 2000;108:1–13. - PubMed
-
- Mechoulam R, Hanus LO, Pertwee R, Howlett AC. Early phytocannabinoid chemistry to endocannabinoids and beyond. Nat Rev Neurosci. 2014;15:757–764. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
